Concepedia

Millicent Embry

ME

8

Publications

2K

Citations

8

H-Index

2001

Active since

Affiliations

Sutro Biopharma (United States)(Current)

Novartis (United States)

Millicent Embry is an author at Sutro Biopharma (United States) specializing in cancer research, tumor biology, and radiation oncology.

Top concepts

Publications per year

2001–2023

8

Publications

8

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Hui Gao, Joshua M. Korn, Stéphane Ferretti et al. · Nature Medicine · 2015 · 1.4K citations

, , +10

Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel.

Dechao Yu, Yu Chen, Jeanette Dilley et al. · PubMed · 2001 · 175 citations

, , +15

CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons <i>In vitro</i> and <i>In vivo</i>

Archie Tse, Katherine G. Rendahl, Tahir Sheikh et al. · Clinical Cancer Research · 2007 · 149 citations

Neutralization of Prolactin Receptor Function by Monoclonal Antibody LFA102, a Novel Potential Therapeutic for the Treatment of Breast Cancer

Jason S. Damiano, Katherine G. Rendahl, Christopher Karim et al. · Molecular Cancer Therapeutics · 2012 · 73 citations · Full text

CHIR-258 Is Efficacious in A Newly Developed Fibroblast Growth Factor Receptor 3–Expressing Orthotopic Multiple Myeloma Model in Mice

Xiaohua Xin, Tinya J. Abrams, Paul W. Hollenbach et al. · Clinical Cancer Research · 2006 · 66 citations

Rows per page

1–5 of 8